文献速递心外重症与机械循环支持

急性呼吸窘迫综合征接受ECMO患者的肺顺应性与结局

Lung Compliance and Outcomes in Patients With Acute Respiratory Distress Syndrome Receiving ECMO.
PubMed 文献 · Ann Thorac Surg · 2019-03-02

该研究在韩国9家医院回顾性分析了56例接受ECMO的急性呼吸窘迫综合征患者,收集ECMO前及ECMO后0、4、24、48小时的呼吸机参数。结果显示ECMO开始后吸气峰压、高于呼气末正压、潮气量和呼吸频率均降低,而肺顺应性无显著变化;ECMO前及支持期间肺顺应性较高者6个月生存更优。

要点

  • ECMO启动后潮气量、吸气峰压和呼吸频率降低,但肺顺应性无显著变化。
  • ECMO前及支持期间肺顺应性较高者6个月生存更优。
  • 肺顺应性可能是接受ECMO的ARDS患者结局的重要预测指标,尚需更大样本验证。

核心结论

  • 肺顺应性无论ECMO前还是ECMO期间,均可能是接受ECMO的急性呼吸窘迫综合征患者结局的重要预测指标,但需更大临床研究确认。

研究设计与样本

  • 韩国9家医院的回顾性分析,纳入56例接受ECMO的急性呼吸窘迫综合征患者,收集ECMO前及ECMO后0、4、24、48小时呼吸机参数并计算时间加权平均值。

主要发现

  • 患者平均年龄55.5岁,住院死亡率和6个月死亡率分别为48.1%和54.0%,ECMO中位时长9.4天。
  • ECMO开始后吸气峰压、高于呼气末正压、潮气量和呼吸频率降低,肺顺应性无显著变化。
  • ECMO前及支持期间,6个月生存者潮气量和肺顺应性高于非生存者。
  • Cox模型中肺顺应性(OR 0.961,95%CI 0.928~0.995)和时间加权平均肺顺应性(OR 0.943,95%CI 0.903~0.986)均与6个月死亡率显著相关。
  • Kaplan-Meier曲线显示ECMO前肺顺应性较高者6个月随访生存时间更长。

临床怎么用

  • 对接受ECMO的ARDS患者,可关注ECMO前及支持期间的肺顺应性,作为预后评估的参考指标。

局限性

  • 为回顾性分析,样本量仅56例,结果需更大规模临床研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited data are available regarding mechanical ventilation strategies in patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation (ECMO). METHODS: A retrospective analysis of acute respiratory distress syndrome patients on ECMO was conducted in 9 hospitals in Korea. Data on ventilator settings (pre-ECMO and 0, 4, 24, and 48 hours after ECMO) were collected. Based on the effect of the duration and intensity of mechanical ventilator on outcomes, time-weighted average values were calculated for ventilator parameters. RESULTS: The 56 patients included in the study had a mean age of 55.5 years. The hospital and 6-month mortality rates were 48.1% and 54.0%, respectively, with a median ECMO duration of 9.4 days. After initiation of ECMO, peak inspiratory pressure, above positive end-expiratory pressure, tidal volume, and respiration rate were reduced, while lung compliance did not change significantly. Before and during ECMO support, tidal volume and lung compliance were higher in 6-month survivors than in nonsurvivors. In Cox proportional models, both lung compliance (odds ratio, 0.961; 95% confidence interval, 0.928 to 0.995) and time-weighted average-lung compliance (odds ratio, 0.943; 95% confidence interval, 0.903 to 0.986) were significantly associated with 6-month mortality. Kaplan-Meier curves revealed that patients with higher lung compliance before ECMO had a longer survival time at the 6-month follow-up than did those with lower lung compliance. CONCLUSIONS: Lung compliance, whether before or during ECMO, may be an important predictor of outcome in acute respiratory distress syndrome patients receiving ECMO. However, this result requires confirmation in larger clinical studies.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kim HS, Kim JH, Chung CR, et al. Lung Compliance and Outcomes in Patients With Acute Respiratory Distress Syndrome Receiving ECMO. Ann Thorac Surg. 2019. PMID: 30836100. doi:10.1016/j.athoracsur.2019.01.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。